Advanced detection of cervical cancer biomarkers using engineered filamentous phage nanofibers
Applied Microbiology and Biotechnology · 2024
DOI: 10.1007/s00253-024-13058-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Microbiology and Biotechnology, 2024. Verfasst von Xu Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The Second Hospital of Jilin University, 218 Ziqiang St, Changchun, 130041, Jilin, China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Nanofibers, Inovirus. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jilin Province, Jilin Provincial Scientific and Technological Development Program.
Abstract (Originalsprache)
Cervical cancer is a major global health concern, characterized by its high incidence and mortality rates. The detection of tumor markers is crucial for managing cancer, making treatment decisions, and monitoring disease progression. Vascular endothelial growth factor (VEGF) and programmed death-ligand 1 (PDL-1) are key targets in cervical cancer therapy and valuable biomarkers in predicting treatment response and prognosis. In this study, we found that combining the measurement of VEGF and soluble PDL-1 can be used for diagnosing and evaluating the progression of cervical cancer. To explore a more convenient approach for detecting and assessing cervical cancer, we designed and prepared an engineered fd bacteriophage, a human-safe viral nanofiber, equipped with two peptides targeting VEGF and PD-L1. The dual-display phage nanofiber specifically recognizes and binds to both proteins. Utilizing this nanofiber as a novel capture agent, we developed a new enzyme-linked immunosorbent assay (ELISA) method. This method shows significantly enhanced detection sensitivity compared to conventional ELISA methods, which use either anti-VEGF or anti-PD-L1 antibodies as capture agents. Therefore, the phage dual-display nanofiber presents significant potential in detecting cancer markers, evaluating medication efficacy, and advancing immunotherapy drug development. Key points • The combined measurement of VEGF and soluble Programmed Death-Ligand 1(sPD-L1) demonstrates an additive effect in the diagnosis of cervical cancer. Fd phage nanofibers have been ingeniously engineered to display peptides that bind to VEGF and PD-L1, enabling the simultaneous detection of both proteins within a single assay • Genetically engineered phage nanofibers, adorned with two distinct peptides, can be utilized for the diagnosis and prognosis of cancer and can be mass-produced cost-effectively through bacterial infections • Employing dual-display fd phage nanofibers as capture probes, the phage ELISA method exhibited significantly enhanced detection sensitivity compared to traditional sandwich ELISA. Furthermore, phage ELISA facilitates the detection of a single protein or the simultaneous detection of multiple proteins, rendering them powerful tools for protein analysis and diagnosis across various fields, including cancer research Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, The Second Hospital of Jilin University, 218 Ziqiang St, Changchun, 130041, Jilin, China.
- Jilin Provincial Key Laboratory On Molecular and Chemical Genetic, The Second Hospital of Jilin University, 218 Ziqiang St, Changchun, 130041, Jilin, China. wangyicun@jlu.edu.cn.
- Department of Obstetrics and Gynecology, The Second Hospital of Jilin University, 218 Ziqiang St, Changchun, 130041, Jilin, China. linyang@jlu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jilin Province
- Jilin Provincial Scientific and Technological Development Program
Zitieren
APA
Zhou, X., Wang, Y., Bao, M., Chu, Y., Liu, R., Chen, Q., & Lin, Y. (2024). Advanced detection of cervical cancer biomarkers using engineered filamentous phage nanofibers. Applied Microbiology and Biotechnology. https://doi.org/10.1007/s00253-024-13058-w
Vancouver
Zhou X, Wang Y, Bao M, Chu Y, Liu R, Chen Q, et al. Advanced detection of cervical cancer biomarkers using engineered filamentous phage nanofibers. Applied Microbiology and Biotechnology. 2024. doi:10.1007/s00253-024-13058-w
BibTeX
@article{Zhou2024,
author = {Zhou, Xu and Wang, Yicun and Bao, Meijing and Chu, Yuqing and Liu, Ruixue and Chen, Qi and Lin, Yang},
title = {Advanced detection of cervical cancer biomarkers using engineered filamentous phage nanofibers},
journal = {Applied Microbiology and Biotechnology},
year = {2024},
doi = {10.1007/s00253-024-13058-w}
}
EUVIMED